F
Fennec Pharmaceuticals Inc
F:RV41
Fennec Pharmaceuticals Inc
F:RV41
Price:
8.2
EUR
Market Closed
Market Cap:
€224m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
F
|
Fennec Pharmaceuticals Inc
F:RV41
|
US |
|
G
|
GoDaddy Inc
F:38D
|
US |
|
M
|
Macy's Inc
DUS:FDO
|
US |
|
R
|
Range Resources Corp
XBER:RAX
|
US |
|
T
|
Toronto-Dominion Bank
XMUN:TDB
|
CA |
|
G
|
Global Power Synergy PCL
SET:GPSC
|
TH |
|
S
|
Scor SE
F:SDRC
|
FR |
|
Sulzer AG
SIX:SUN
|
CH |
|
A
|
Asia Plus Group Holdings PCL
SET:ASP
|
TH |
|
Swedbank AB
F:FRY
|
SE |
|
D
|
Dominion Energy Inc
SWB:DOD
|
US |
|
M
|
Murata Manufacturing Co Ltd
F:MUR1
|
JP |
|
Perdoceo Education Corp
NASDAQ:PRDO
|
US |
|
C
|
CMC Materials Inc
F:CTD
|
US |
|
Selvaag Bolig ASA
F:S2B
|
NO |
Wall St Price Targets
RV41 Price Targets Summary
Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc
Wall Street analysts forecast RV41 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RV41 is 16.28 EUR with a low forecast of 13.82 EUR and a high forecast of 19.89 EUR.
Lowest Forecast
Price Target
13.82
EUR
69% Upside
Average Forecast
Price Target
16.28
EUR
99% Upside
Highest Forecast
Price Target
19.89
EUR
143% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV41's stock price target?
Price Target
16.28
EUR
16.28
EUR
According to Wall Street analysts, the average 1-year price target for RV41 is 16.28 EUR with a low forecast of 13.82 EUR and a high forecast of 19.89 EUR.
What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
22%
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
